We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.3%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAMP icon
1151
LiveRamp
RAMP
$2.29B
$105K 0.01%
2,174
+845
+64% +$45.8K
UBSI icon
1152
United Bankshares
UBSI
$6.57B
$105K 0.01%
2,818
-162
-5% -$6.08K
AKRX
1153
DELISTED
Akorn Inc
AKRX
$105K 0.01%
20,393
+19,724
+2,948% +$75.9K
BSBR icon
1154
Santander
BSBR
$43.4B
$104K 0.01%
+9,078
New +$98.7K
GEN icon
1155
Gen Digital
GEN
$17.6B
$104K 0.01%
4,771
-13,814
-74% -$297K
HR icon
1156
Healthcare Realty
HR
$6.61B
$104K 0.01%
3,808
-9,607
-72% -$271K
MET icon
1157
MetLife
MET
$61.6B
$104K 0.01%
2,094
-14,630
-87% -$688K
MPT
1158
Medical Properties Trust
MPT
$2.47B
$104K 0.01%
5,999
-21,580
-78% -$389K
SLAB icon
1159
Silicon Laboratories
SLAB
$7.21B
$104K 0.01%
998
+891
+833% +$86K
WOR icon
1160
Worthington Enterprises
WOR
$2.81B
$104K 0.01%
4,198
+1,791
+74% +$42K
EVA
1161
DELISTED
Enviva Inc.
EVA
$104K 0.01%
3,299
+3,199
+3,199% +$101K
KAMN
1162
DELISTED
Kaman Corp
KAMN
$104K 0.01%
1,631
+412
+34% +$24.7K
TNAV
1163
DELISTED
Telenav Inc.
TNAV
$104K 0.01%
13,002
+7,726
+146% +$53.9K
AHRT
1164
AH Realty Trust
AHRT
$504M
$103K 0.01%
+6,223
New +$101K
BLUE
1165
DELISTED
bluebird bio
BLUE
$103K 0.01%
63
+30
+91% +$51.9K
HEXO
1166
DELISTED
HEXO Corp. Common Shares
HEXO
$103K 0.01%
343
+60
+21% +$22.2K
IVOG icon
1167
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.72B
$102K 0.01%
1,450
-5,418
-79% -$372K
LOGI icon
1168
Logitech
LOGI
$15.1B
$102K 0.01%
2,581
+1,964
+318% +$76.6K
UTSL icon
1169
Direxion Daily Utilities Bull 3X ETF
UTSL
$37.3M
$102K 0.01%
2,724
+2,449
+891% +$86.8K
PVG
1170
DELISTED
PRETIUM RESOURCES INC.
PVG
$102K 0.01%
10,259
-16,864
-62% -$143K
CBM
1171
DELISTED
Cambrex Corporation
CBM
$102K 0.01%
2,188
+883
+68% +$37K
QRVO icon
1172
Qorvo
QRVO
$8.66B
$101K 0.01%
1,522
-2,750
-64% -$191K
TCRT icon
1173
Alaunos Therapeutics
TCRT
$4.84M
$101K 0.01%
116
+115
+11,500% +$79.1K
AUY
1174
DELISTED
Yamana Gold, Inc.
AUY
$101K 0.01%
40,323
-65,414
-62% -$144K
ALE
1175
DELISTED
Allete
ALE
$100K 0.01%
1,212
+447
+58% +$36.8K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.